Sanofi Stock Market Capitalization
SNYNF Stock | USD 95.54 1.54 1.64% |
Sanofi fundamentals help investors to digest information that contributes to Sanofi's financial success or failures. It also enables traders to predict the movement of Sanofi Pink Sheet. The fundamental analysis module provides a way to measure Sanofi's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sanofi pink sheet.
Sanofi |
Sanofi Company Market Capitalization Analysis
Sanofi's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Sanofi Market Capitalization | 120.25 B |
Most of Sanofi's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sanofi is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Competition |
Based on the recorded statements, the market capitalization of Sanofi is about 120.25 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The market capitalization for all United States stocks is significantly lower than that of the firm.
Sanofi Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sanofi's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Sanofi could also be used in its relative valuation, which is a method of valuing Sanofi by comparing valuation metrics of similar companies.Sanofi is currently under evaluation in market capitalization category among related companies.
Sanofi Fundamentals
Return On Equity | 0.0959 | |||
Return On Asset | 0.0607 | |||
Profit Margin | 0.15 % | |||
Operating Margin | 0.26 % | |||
Current Valuation | 135.37 B | |||
Shares Outstanding | 1.25 B | |||
Shares Owned By Insiders | 11.23 % | |||
Shares Owned By Institutions | 46.69 % | |||
Price To Earning | 7.73 X | |||
Price To Book | 1.60 X | |||
Price To Sales | 2.73 X | |||
Revenue | 45.39 B | |||
Gross Profit | 31.69 B | |||
EBITDA | 10.76 B | |||
Net Income | 6.72 B | |||
Cash And Equivalents | 6.9 B | |||
Cash Per Share | 5.51 X | |||
Total Debt | 14.86 B | |||
Debt To Equity | 0.30 % | |||
Current Ratio | 1.30 X | |||
Book Value Per Share | 58.33 X | |||
Cash Flow From Operations | 10.52 B | |||
Earnings Per Share | 5.77 X | |||
Price To Earnings To Growth | 1.63 X | |||
Target Price | 123.28 | |||
Number Of Employees | 58 | |||
Beta | 0.41 | |||
Market Capitalization | 120.25 B | |||
Total Asset | 124.58 B | |||
Z Score | 4.8 | |||
Annual Yield | 0.04 % | |||
Five Year Return | 3.83 % | |||
Net Asset | 124.58 B | |||
Last Dividend Paid | 3.56 |
About Sanofi Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sanofi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanofi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanofi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sanofi in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sanofi's short interest history, or implied volatility extrapolated from Sanofi options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Sanofi Pink Sheet analysis
When running Sanofi's price analysis, check to measure Sanofi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi is operating at the current time. Most of Sanofi's value examination focuses on studying past and present price action to predict the probability of Sanofi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi's price. Additionally, you may evaluate how the addition of Sanofi to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |